New PET tracer could sharpen amyloidosis diagnosis
Diagnosis
Completed
This phase 2 trial tested a radioactive tracer called 124I-AT-01 to see how well it can measure amyloid buildup in organs like the heart, kidneys, liver, and spleen using PET/CT scans. 33 adults with systemic amyloidosis received the tracer twice, six weeks apart. The goal was to…
Phase: PHASE2 • Sponsor: Attralus, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 13:34 UTC